Randomized controlled trial: Combination therapy of Antithrombin and Recombinant-thrombomodulin for septic DIC
Not Applicable
Recruiting
- Conditions
- Sepsis associated with disseminated intravascular coagulation (DIC)
- Registration Number
- JPRN-UMIN000002705
- Lead Sponsor
- Kagoshima University Hospital Intensive Care Units
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1)< Fifteen years of age, 2)Hematopoetic malignancy, 3)Comcomitant treatment with cartinostatics or irradiation, 4)Liver cirrhosis classified as Child-Pugh C
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of DIC score, coagulation and fibrinolytic markers six days after thrombomodulin
- Secondary Outcome Measures
Name Time Method Twenty-eight day mortality